Review



mouse derived c2c12 myoblasts  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    ATCC mouse derived c2c12 myoblasts
    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in <t>C2C12</t> myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
    Mouse Derived C2c12 Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1087 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+derived+c2c12+myoblasts/C2C12%3B+Muscle+Myoblast%3B+Mouse/pm40218975-46-0-3
    Average 97 stars, based on 1087 article reviews
    mouse derived c2c12 myoblasts - by Bioz Stars, 2026-09
    97/100 stars

    Images

    1) Product Images from "Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy."

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy.

    Journal: Nutrients

    doi: 10.3390/nu17071217

    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in C2C12 myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
    Figure Legend Snippet: Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in C2C12 myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.

    Techniques Used: XTT Assay, Quantitative RT-PCR, Control, Western Blot

    Figure 2. PMLE enhances mitochondrial biogenesis and protein synthesis signaling pathways in C2C12 myoblasts. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels after PMLE (10, 50, 100 ng/mL) treatment. Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot analysis of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; corresponding total proteins were used as loading controls. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control. PMLE, Pueraria montana var. lobata extract.
    Figure Legend Snippet: Figure 2. PMLE enhances mitochondrial biogenesis and protein synthesis signaling pathways in C2C12 myoblasts. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels after PMLE (10, 50, 100 ng/mL) treatment. Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot analysis of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; corresponding total proteins were used as loading controls. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control. PMLE, Pueraria montana var. lobata extract.

    Techniques Used: Protein-Protein interactions, Quantitative RT-PCR, Control, Western Blot

    Figure 3. PMLE alleviates dexamethasone (DEX)-induced muscle atrophy and promotes myogenic differentiation in C2C12 myotubes. (A) Immunofluorescence staining of MyHC (green) and nuclei (DAPI, blue) in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). The right panel shows the quantification of myotube diameter. (B) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels. Data are normalized to GAPDH and shown as fold change vs. control. (C) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.
    Figure Legend Snippet: Figure 3. PMLE alleviates dexamethasone (DEX)-induced muscle atrophy and promotes myogenic differentiation in C2C12 myotubes. (A) Immunofluorescence staining of MyHC (green) and nuclei (DAPI, blue) in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). The right panel shows the quantification of myotube diameter. (B) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels. Data are normalized to GAPDH and shown as fold change vs. control. (C) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.

    Techniques Used: Immunofluorescence, Staining, Quantitative RT-PCR, Control, Western Blot

    Figure 4. PMLE restores mitochondrial biogenesis and protein synthesis signaling pathways in DEX-induced muscle atrophy. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; total proteins were used as loading controls. Band intensities are presented as fold change vs. control. Statistical significance: * p < 0.05 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.
    Figure Legend Snippet: Figure 4. PMLE restores mitochondrial biogenesis and protein synthesis signaling pathways in DEX-induced muscle atrophy. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; total proteins were used as loading controls. Band intensities are presented as fold change vs. control. Statistical significance: * p < 0.05 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.

    Techniques Used: Protein-Protein interactions, Quantitative RT-PCR, Control, Western Blot

    Related Articles

    Cell Culture:

    Article Title: The effect of voluntary exercise on light cycle stress-induced metabolic resistance
    Article Snippet: .. Mouse-derived C2C12 myoblasts (ATCC, VA, USA) were cultured in a growth medium containing 90% Dulbecco’s modified Eagle’s medium (DMEM; Gibco, NY, USA), 10% fetal bovine serum, and 100 unit/mL penicillin– streptomycin (PS; Gibco) at 37 °C and 5% CO 2 . ..

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy.
    Article Snippet: Secondary antibodies, including horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG, were obtained from Enzo Life Sciences (Farmingdale, NY, USA). .. Mouse-derived C2C12 myoblasts (American Type Culture Collection; Manassas, VA, USA; ATCC-CRL 1772) were cultured in a growth medium (GM; DMEM containing 10% heat-inactivated FBS and antibiotics) at 37 ◦C under 5% CO2. ..

    Article Title: Modulatory roles of capsaicin on thermogenesis in C2C12 myoblasts and the skeletal muscle of mice.
    Article Snippet: Capsaicin, a polyphenol, is known to regulate energy expenditure and thermogenesis in adipocytes and muscles.. However, its role in modulating uncoupling proteins (UCPs) and adenosine triphosphate (ATP)-dependent thermogenesis in muscles remains unclear.. This study investigated the mechanisms underlying the role of capsaicin in modulating the UCPand ATP-dependent thermogenesis in C2C12 myoblasts, as well as the gastrocnemius (GM) and soleus muscles (SM) of mice.

    Article Title: Silencing of dopamine receptor D5 inhibits the browning of 3T3-L1 adipocytes and ATP-consuming futile cycles in C2C12 muscle cells.
    Article Snippet: Background: As a part of the catecholamines, dopamine receptors (DRs) have not been extensively studied like β3-AR in the thermogenesis process.. The present study investigates the effect of DRD5 in browning events and ATP-consuming futile cycles.. Methods: siRNA technology, qPCR, immunoblot analysis, immunofluorescence, and staining methods were used to investigate the effect of DRD5 on 3T3-L1 and C2C12 cells.

    Article Title: The effect of voluntary exercise on light cycle stress-induced metabolic resistance.
    Article Snippet: .. Mouse-derived C2C12 myoblasts (ATCC, VA, USA) were cultured in a growth medium containing 90% Dulbecco’s modified Eagle’s medium (DMEM; Gibco, NY, USA), 10% fetal bovine serum, and 100 unit/mL penicillin– streptomycin (PS; Gibco) at 37 °C and 5% CO2. ..

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy
    Article Snippet: Secondary antibodies, including horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG, were obtained from Enzo Life Sciences (Farmingdale, NY, USA). .. Mouse-derived C2C12 myoblasts (American Type Culture Collection; Manassas, VA, USA; ATCC-CRL 1772) were cultured in a growth medium (GM; DMEM containing 10% heat-inactivated FBS and antibiotics) at 37 °C under 5% CO 2 . ..

    Modification:

    Article Title: The effect of voluntary exercise on light cycle stress-induced metabolic resistance
    Article Snippet: .. Mouse-derived C2C12 myoblasts (ATCC, VA, USA) were cultured in a growth medium containing 90% Dulbecco’s modified Eagle’s medium (DMEM; Gibco, NY, USA), 10% fetal bovine serum, and 100 unit/mL penicillin– streptomycin (PS; Gibco) at 37 °C and 5% CO 2 . ..

    Article Title: Silencing of dopamine receptor D5 inhibits the browning of 3T3-L1 adipocytes and ATP-consuming futile cycles in C2C12 muscle cells.
    Article Snippet: Background: As a part of the catecholamines, dopamine receptors (DRs) have not been extensively studied like β3-AR in the thermogenesis process.. The present study investigates the effect of DRD5 in browning events and ATP-consuming futile cycles.. Methods: siRNA technology, qPCR, immunoblot analysis, immunofluorescence, and staining methods were used to investigate the effect of DRD5 on 3T3-L1 and C2C12 cells.

    Article Title: The effect of voluntary exercise on light cycle stress-induced metabolic resistance.
    Article Snippet: .. Mouse-derived C2C12 myoblasts (ATCC, VA, USA) were cultured in a growth medium containing 90% Dulbecco’s modified Eagle’s medium (DMEM; Gibco, NY, USA), 10% fetal bovine serum, and 100 unit/mL penicillin– streptomycin (PS; Gibco) at 37 °C and 5% CO2. ..



    Similar Products

    97
    ATCC mouse derived c2c12 myoblasts
    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in <t>C2C12</t> myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
    Mouse Derived C2c12 Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+derived+c2c12+myoblasts/C2C12%3B+Muscle+Myoblast%3B+Mouse/pm40218975-46-0-3
    Average 97 stars, based on 1 article reviews
    mouse derived c2c12 myoblasts - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    ATCC mouse skeletal muscle derived myoblasts
    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in <t>C2C12</t> myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
    Mouse Skeletal Muscle Derived Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+derived+c2c12+myoblasts/C2C12%3B+Muscle+Myoblast%3B+Mouse/pmc11676106-306-0-11
    Average 97 stars, based on 1 article reviews
    mouse skeletal muscle derived myoblasts - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    99
    ATCC mouse derived c2c12 myoblast cell line
    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in <t>C2C12</t> myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
    Mouse Derived C2c12 Myoblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+derived+c2c12+myoblasts/C2C12/10__1007_slash_s10068___024___01675___0-63-1-19
    Average 99 stars, based on 1 article reviews
    mouse derived c2c12 myoblast cell line - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC mouse skeletal myoblast derived cells c2c12
    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in <t>C2C12</t> myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
    Mouse Skeletal Myoblast Derived Cells C2c12, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+derived+c2c12+myoblasts/C2C12/pm37562939-78-7-12
    Average 99 stars, based on 1 article reviews
    mouse skeletal myoblast derived cells c2c12 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in C2C12 myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.

    Journal: Nutrients

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy.

    doi: 10.3390/nu17071217

    Figure Lengend Snippet: Figure 1. Effects of Pueraria montana var. lobata extract (PMLE) on myogenic differentiation in C2C12 myoblasts. (A) XTT assay showing no significant effect of PMLE (10, 50, 100 ng/mL) on C2C12 cell viability. Data are mean ± SD. (B) Phase-contrast images of myotube formation after PMLE treatment. Scale bar = 50 µm. (C) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels after PMLE treatment. Data are normalized to GAPDH and shown as fold change vs. control. (D) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.

    Article Snippet: Mouse-derived C2C12 myoblasts (American Type Culture Collection; Manassas, VA, USA; ATCC-CRL 1772) were cultured in a growth medium (GM; DMEM containing 10% heat-inactivated FBS and antibiotics) at 37 ◦C under 5% CO2.

    Techniques: XTT Assay, Quantitative RT-PCR, Control, Western Blot

    Figure 2. PMLE enhances mitochondrial biogenesis and protein synthesis signaling pathways in C2C12 myoblasts. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels after PMLE (10, 50, 100 ng/mL) treatment. Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot analysis of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; corresponding total proteins were used as loading controls. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control. PMLE, Pueraria montana var. lobata extract.

    Journal: Nutrients

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy.

    doi: 10.3390/nu17071217

    Figure Lengend Snippet: Figure 2. PMLE enhances mitochondrial biogenesis and protein synthesis signaling pathways in C2C12 myoblasts. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels after PMLE (10, 50, 100 ng/mL) treatment. Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot analysis of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; corresponding total proteins were used as loading controls. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control. PMLE, Pueraria montana var. lobata extract.

    Article Snippet: Mouse-derived C2C12 myoblasts (American Type Culture Collection; Manassas, VA, USA; ATCC-CRL 1772) were cultured in a growth medium (GM; DMEM containing 10% heat-inactivated FBS and antibiotics) at 37 ◦C under 5% CO2.

    Techniques: Protein-Protein interactions, Quantitative RT-PCR, Control, Western Blot

    Figure 3. PMLE alleviates dexamethasone (DEX)-induced muscle atrophy and promotes myogenic differentiation in C2C12 myotubes. (A) Immunofluorescence staining of MyHC (green) and nuclei (DAPI, blue) in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). The right panel shows the quantification of myotube diameter. (B) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels. Data are normalized to GAPDH and shown as fold change vs. control. (C) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.

    Journal: Nutrients

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy.

    doi: 10.3390/nu17071217

    Figure Lengend Snippet: Figure 3. PMLE alleviates dexamethasone (DEX)-induced muscle atrophy and promotes myogenic differentiation in C2C12 myotubes. (A) Immunofluorescence staining of MyHC (green) and nuclei (DAPI, blue) in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). The right panel shows the quantification of myotube diameter. (B) qRT-PCR analysis of MyHC, MyoD, and myogenin mRNA levels. Data are normalized to GAPDH and shown as fold change vs. control. (C) Western blot analysis of MyHC, MyoD, and myogenin protein levels. GAPDH was used as a loading control. Band intensities are shown as fold change vs. control. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.

    Article Snippet: Mouse-derived C2C12 myoblasts (American Type Culture Collection; Manassas, VA, USA; ATCC-CRL 1772) were cultured in a growth medium (GM; DMEM containing 10% heat-inactivated FBS and antibiotics) at 37 ◦C under 5% CO2.

    Techniques: Immunofluorescence, Staining, Quantitative RT-PCR, Control, Western Blot

    Figure 4. PMLE restores mitochondrial biogenesis and protein synthesis signaling pathways in DEX-induced muscle atrophy. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; total proteins were used as loading controls. Band intensities are presented as fold change vs. control. Statistical significance: * p < 0.05 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.

    Journal: Nutrients

    Article Title: Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy.

    doi: 10.3390/nu17071217

    Figure Lengend Snippet: Figure 4. PMLE restores mitochondrial biogenesis and protein synthesis signaling pathways in DEX-induced muscle atrophy. (A) qRT-PCR analysis of SIRT1 and PGC-1α mRNA levels in C2C12 myotubes treated with DEX (100 µM) and/or PMLE (100 ng/mL). Data are normalized to GAPDH and shown as fold change vs. control. (B) Western blot of SIRT1 and PGC-1α protein levels. GAPDH was used as a loading control. (C) Western blot of phosphorylated AMPK (p-AMPK); total AMPK was used as a control. (D) Western blot of p-AKT, p-mTOR, p-p70S6K, and p-4E-BP1; total proteins were used as loading controls. Band intensities are presented as fold change vs. control. Statistical significance: * p < 0.05 vs. control group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. DEX-treated group. PMLE, Pueraria montana var. lobata extract.

    Article Snippet: Mouse-derived C2C12 myoblasts (American Type Culture Collection; Manassas, VA, USA; ATCC-CRL 1772) were cultured in a growth medium (GM; DMEM containing 10% heat-inactivated FBS and antibiotics) at 37 ◦C under 5% CO2.

    Techniques: Protein-Protein interactions, Quantitative RT-PCR, Control, Western Blot